Диссертация (1139465), страница 57
Текст из файла (страница 57)
- Vol. 268. - P. 1280 - 1286.230. Identifies members of the ESAT-6 family as immune dominant / R.Skjot [et al.] // Infect. Immun. – 2000. – Vol. 68. – P. 214–220.231. Immune reconstitution syndrome after highly active antiretroviraltherapy in human immunodeficiency virus-infected Thai children / T. Puthanakit[et al.] // Pediatr. Infect. Dis. J. - 2006. - № 25. – P. 53–58.232. Impact of HIV infection on the development, clinical presentation, andoutcome of tuberculosis among children in Abidjan, Cote d’Ivoire / Y.D. Mukadi[et al.] //AIDS. - 1997. – Vol.11, № 9. – P. 1151-1158.339233. Impact of HIV-1 co infection on presentation and hospital relatedmortality in children with culture proven pulmonary tuberculosis in Durban, SouthAfrica / P.M.
Jeena [et al.] // Int. J. of Tuberc. and Lung Dis. – 2002. – Vol. 6, №8.– P. 672-678.234. Impact of human immunodeficiency virus 1 infection on clinical presentation, treatment outcome and survival in a cohort of Ethiopian children with tuberculosis / I.B. Palme [et al.] // Pediatr. Infect. Dis. J. – 2002. – Vol.
21, № 11. –P. 1053-1061.235. Impact of pulmonary tuberculosis on survival of HIV-infected adults:a prospective epidemiologic study in Uganda / C.C. Whalen [et al.] // AIDS. 2000. - № 14. – P. 1219-1228.236. Increased survival of persons with tuberculosis and human immunodeficiency virus infection, 1991-2000 / M.K. Leonard [et al.] // Clin.
Infect. Dis. –2002. – Vol. 34, № 7. – P. 1002-1007.237. Influence of bacillus Calmette-Guerin vaccination at birth and 2months old age on the peripheral blood T-cell subpopulations [gamma/delta andalpha-beta T-cell] / Y.Tastan [et al.] // Pediatr. Allerg. Immunol. – 2005. – Vol. 16.– P. 624–629.238. Iseman, M.
D. Treatment of multidrug-resistant tuberculosis / M.D.Iseman // New. Engl. J. Med. – 1993. – Vol. 329, № 11. – P. 784-91.239. Isoniazid preventive therapy for tuberculosis in HIV-1-infected adults:results of a randomized controlled trial / M.P. Hawken [et al.] //AIDS. – 1997. –Vol. 11. – P. 875-882.240. Isoniazid prophylaxis for tuberculosis in HIV infection: a metaanalysis of randomized controlled trials / H.C.
Bucher[et al.] // AIDS. – 1999. - №13. – P. 501-507.241. Jenny-Avital, E.R. Protease inhibitors and rifabutin: isn't the jury stillout? / E.R. Jenny-Avital // Clin. Infect. Dis. – 2001. – Vol. 32, № 2. – P. 322-323.340242. Kumar, A. Clinical Presentation, treatment outcome and survivalamong the HIV infected children with culture confirmed tuberculosis / A. Kumar,S.
Upadhyay, G. Kumari // Current HIV Research. – 2007. – Vol. 5, № 5. – P. 499504.243. Lichterfeld, A. Tuberculosis und HIV-Infection / A. Lichterfeld, R.Ferlinz // Pneumologie. - 1991. - Vol. 45, № 1. - P. 1-8.244. Mantoux Making BCG vaccination programmes safer in the HIV era /T.K.
Mak [et al.] // Lancet. – 2008. – Vol. 372. – P. 786–787.245. Mantoux, Ch. Intradermo reaction de la tuberculine / Ch. Mantoux //Comptesrendus de I Academie des sciencеs. - Paris, 1908. - Vol. 147. – P. 355357.246. Mediastinaltuberculous lymphadenitis: CT manifestations / J.G. Im [etal.] // Radiology. - 2002. - Vol. 164. - P. 115-119.247. Medical Research Council Cardiothoracic Epidemiology Grop. Tuberculosis in children: a national survey of notifications in England and Wales in1988. Medical Research Council Cardiothoracic Epidemiology Group // Arch.
Dis.Child. – 1994. – Vol. 70, № 6. – P. 497-500.248. Miller, F.J.W. Tuberculosis in Children / F.J.W. Miller, Ch. Livingatone // Tubercle. - 1982. – B. 63. – № 3. – P. 234 - 235.249. Moore, D.P. Defining the burden of tuberculosis in a cohort of children enrolled in a pneumococcal vaccine trial / D.P. Moore, S.A. Madhi. - Durban,South Africa, 2008. - 265 p.250. Moore, M. Cross-matching оf TB and AIDS 2003 resistance: TB patients with HIV co-infection, United Sates, 1993-1994 / M. Moore, E. McCray,I.M. Onorato // Publ. Health Rep. – 1999. - Vol.
114. – P. 269 - 277.251. Moses, A.E. Prevalence of HIV-1 infection among patients with leprosy and pulmonary tuberculosis in a. semi-arid region, Nigeria / A.E. Moses,K.A. Adelowo, B.B. Ajayi; II Department of Immunology and Infectious Diseases.341University of Maiduguri; II Departament of Immunology and Infectious Diseas.University of Maiduguri // J.
R. Soc. Health. – 2003, Jun. – Vol. 123, № 2. - P.117-119.252. Mu, A. Clinical analysis of pulmonary infection in patients with acquired immunodeficiency syndrome (ADIS) / A. Mu // Zhonghua-Jie-He-He-HuXi-Za-Zhi. – 1998, Sep. – Vol. 21, № 9. - P. 526-527.253. Mycobacterium tuberculosis in children with human immunodeficiency virus type 1 infection / Y.F. Khouri [et al.] // Pediatr. Infect. Dis. Journ. – 1992.– Vol.11, № 11. – P. 950-955.254. Mycobacterium tuberculosis in children with human immunodeficiency virus type 1 infection / Y.F.
Khouri [et al.] // Pediatr. Infect. Dis. J. – 1992. Vol. 11, № 11. – P. 950-955.255. Net survival of perinatally and postnatally HIV-infected children: apooled analysis of individual data from sub-Saharan Africa / M. Marston [et al.] //Int. J. of Epidemiol. – 2011.
– Vol. 40. – P. 385-396.256. Neurenberger, E. Latent tuberculosis infection: Seminars in Resp. andCritic / E. Neurenberger , W.R. Bishai, J.H.Grosse // Care Med. - 2004. - Vol. 25,№ 3. - P. 317-336.257. No effect of isoniazid prophylaxis for purified protein derivativenegative HIV-infected adults living in a country with endemic tuberculosis: resultsof a randomized trial / D.W. Fitzgerald [et al.] // J. Acquir. Immune Defic. Syndr. –2001. – Vol. 28. – P. 305-307.258. Ormerod, L.P. Rifampicin and isoniazid prophylactic chemotherapyfor tuberculosis / L.P. Ormerod // Arch. Dis.
Child. – 1998. – Vol. 78, № 2. – P.169-71.259. Pai, M. Systematic review: T-cell based assays for the diagnosis of latent tuberculosis infection: an update / M. Pai, A. Zwerling, D. Menzies / /Ann. Int.Med. - 2008. – Vol. 149, № 3. – P. 177-184.342260. Paradoxical reactions of tuberculosis in patients with the acquiredimmunodeficiency syndrome who are treated with highly active antiretroviral therapy / E. Navas [et al.] // Arch. Int. Med. – 2002. – Vol.
162. – P. 97-99.261. Paradoxical worsening of tuberculosis following antiretroviral therapyin patients with AIDS / M. Narita [et al.] // Am. J. Respir. Crit. Care. Med. – 1998.– Vol. 158. – P. 157-161.262. Prevention and treatment of tuberculosis among patients infected withhuman immunodeficiency virus: principles of therapy and revised recommendations / Centers for Disease Control and Prevention. – MMWR.
– 1998. – Vol. 47,RR-20. – P. 342-345263. Prevention of mother-to-child transmission of HIV and the health related Millennium Development Goals: time for a public health approach / E.J.Schouten [et al.] // Lancet. – 2011. – Vol. 378. – P. 282-284.264. Prevention of mother-to-child transmission of human immunodeficiency virus among pregnant women using injecting drugs in Ukraine, 2000.10 /C. Thorne [et al.] // Addiction.
- 2012. – Vol. 107. – P. 118-128.265. Prevention, diagnosis, and treatment of tuberculosis in children andmothers: evidence for action for maternal, neonatal, and child health services /H.Getahun [et al.] // J. of Infect. Dis. – 2012. – Vol. 205(Suppl. 2). – S. 216, S.227.266. Primary isoniazid prophylaxis against tuberculosis in HIV-exposedchildren / S.
Madhi [et al.] // New Eng.- land. J. of Medicine. – 2011. - Vol. 365. –P. 21–31.267. Pyrazinamide and rifampin versus isoniazid for the treatment of latenttuberculosis: improved completion rates but more hepatotoxicity / L. McNeill [etal.] // Chest. – 2003. – Vol. 123. – P. 102-106.343268. Randomized trial of isoniazid versus rifampicin and pyrazinamide forprevention of tuberculosis in HIV-1 infection / N.A. Halsey[ et al.] // Lancet. –1998. – Vol.
351. – P. 786-792.269. Recurrent culture confirmed tuberculosis in human immunodeficiencyvirus infected children / H.S. Schaaf [et al.] // Pediatr. Infect. Dis. J. - 2005. - Vol.24, № 8. – P. 685-691.270. Reduced rate of adverse reactions to the BCG vaccine in children exposed to the vertical transmission of HIV infection and in HIV-infected childrenfrom an endemic setting in Brazil / R.C. De Souza Campos Fernandes [ et al.] //Eur. J. Pediatr. – 2009. – Vol.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
